Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$0.1 - $0.3 $30 - $90
-300 Reduced 0.43%
69,699 $8,000
Q4 2022

Feb 08, 2023

BUY
$0.14 - $0.22 $791 - $1,243
5,650 Added 8.78%
69,999 $12,000
Q1 2022

May 12, 2022

SELL
$0.55 - $0.73 $275 - $365
-500 Reduced 0.77%
64,349 $36,000
Q2 2021

Aug 10, 2021

BUY
$0.66 - $1.23 $3,960 - $7,380
6,000 Added 10.2%
64,849 $71,000
Q1 2021

May 07, 2021

BUY
$0.54 - $1.79 $5,400 - $17,900
10,000 Added 20.47%
58,849 $55,000
Q4 2020

Feb 04, 2021

BUY
$0.4 - $1.01 $800 - $2,020
2,000 Added 4.27%
48,849 $23,000
Q3 2020

Oct 29, 2020

BUY
$0.52 - $1.45 $24,361 - $67,931
46,849 New
46,849 $36,000
Q1 2019

May 08, 2019

SELL
$2.02 - $3.22 $32,322 - $51,523
-16,001 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$2.1 - $3.21 $33,602 - $51,363
16,001 New
16,001 $36,000

About Adamis Pharmaceuticals Corp


  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.